Evidence map›Paper›PMID 20425377›Full record

ReviewCurrent hematologic malignancy reports2007

Epstein-Barr virus-related lymphoproliferative disorders.

Nina D Wagner-Johnston, Richard F Ambinder

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current hematologic malignancy reports, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. EBV Reactivation and Lymphomagenesis: More Questions than Answers.Current hematologic malignancy reports · 2023
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Nina D Wagner-JohnstonSidney Kimmel Comprehensive Cancer Center at Johns Hopkins,1650 Orleans Street, CRB 389, Baltimore, MD 21231, USA.
Richard F Ambinder
Sidney Kimmel Comprehensive Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Esptein-Barr virus (EBV) is a ubiquitous gammaherpesvirus that persists in carriers as a lifelong, mostly asymptomatic infection. EBV is associated with a variety of lymphomas and lymphoproliferative disorders. In this review we provide an update of the relevant literature on EBV-associated lymphoproliferative disorders, with particular emphasis on epidemiology, pathogenesis, and novel treatment approaches.

Indexed as

Epstein-Barr Virus InfectionsAdoptive TransferAntibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedAntineoplastic Combined Chemotherapy ProtocolsAntiretroviral Therapy, Highly ActiveAntiviral AgentsBrain NeoplasmsClinical Trials as TopicCombined Modality TherapyHerpesvirus 4, HumanHumansImmunocompromised HostImmunologic FactorsImmunosuppressive AgentsImmunotherapyAntibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedAntiviral AgentsImmunologic FactorsImmunosuppressive AgentsRituximabRNA, ViralViral Proteins

Identifiers

PMID20425377
OpenAlexW2067780564

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.